ITM and Debiopharm announce imaging of first subject in solid tumours trial
ITM and Swiss-based Debiopharm have announced the imaging of the first subject in a new study arm (Part D) of the Phase I/II trial. The post ITM and Debiopharm announce imaging of first subject in solid tumours trial appeared first on Medical Device Network.

The post ITM and Debiopharm announce imaging of first subject in solid tumours trial appeared first on Medical Device Network.